ArticlePloS one2026
Stratified and geographic patterns of depression and anxiety in Mozambican women: Mental health policy implications.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify the risk factors of depression and anxiety among ever-married Mozambican women, including rural-urban, internet-use, and province- wide geographic inequalities, and to inform mental health policy. METHODOLOGY: This study used cross-sectional design and 13,183 ever-married women aged 15-49 years from the nationally representative Mozambique Demographic and Health Survey (MDHS) 2022-2023. The outcome variables were assessed using the Patients Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7), with score (>=10) indicating depression and anxiety respectively. Survey-weighted multivariate logistic regression models were used to determine factors associated with anxiety and depression, and results were presented as adjusted odds ratios (aORs) with corresponding 95% confidence intervals (95% CIs).
findingsAmong all women, 11% reported anxiety symptoms, and 10% reported depressive symptoms. Women aged 35-39 years associated the highest odds of anxiety (aOR = 2.06, 95% CI: 1.48-2.87) and depression (aOR = 1.49, 95% CI: 1.07-2.08). Additionally, women aged 45-49 years showed the second-highest odds of anxiety (aOR = 1.58, 95% CI: 1.12-2.23), while the second-highest odds of depressive symptoms were also observed among women aged 45-49 years (aOR = 1.32, 95% CI: 0.92-1.89), compared with women aged 15-19 years. Age at first sex (<18 years) was significantly associated with anxiety (aOR = 1.66, 95% CI: 1.25-2.19) and depression (aOR = 1.60, 95% CI: 1.17-2.18) compared to aged ≥18 years. Women participation in decision making autonomy significantly associated with lower odds of anxiety (aOR = 0.67, 95% CI: 0.54-0.83) and depression (aOR = 0.65, 95% CI: 0.53-0.81). Household asset ownership of (aOR = 0.76, 95% CI: 0.62-0.92), and improved sanitation facilities associated with lower odds for anxiety (aOR = 0.76, 95% CI: 0.60-0.98) only. While, improved household materials (aOR = 1.37, 95% CI: 1.07-1.76) and internet use (aOR = 1.46, 95% CI: 1.07-1.99) were associated with higher anxiety. Geographically, women Cabo Delgado and Zambézia, Nampula consistently associated with higher odds while Gaza associated with lower odds of both anxiety and depression compared to Maputo City respectively.
conclusionsTargeted mental health symptoms interventions should prioritize aged 35-49 years and high burden provinces such as Nampula strengthening women's decision-making autonomy. Integrating routine mental health symptoms screening into reproductive and women's health services may help decrease anxiety and depression among Mozambican women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.